Mira, a leading hormonal health company, announces the launch of the first Hormone Innovators Awards 2025. As part of Mira’s annual Sex Hormones Awareness Week, this initiative aims to spotlight groundbreaking work, promote awareness of hormonal health challenges, and provide a platform for companies and individuals driving change in the industry.
This year marks 120 years since the discovery of hormones, a breakthrough that transformed medicine. Yet, despite their critical role in health, hormonal innovations remain underfunded and overlooked. Women’s health, long underserved and underfunded, received just 2.3% of VC funding in 2024 compared to general healthcare. The Hormone Innovators Awards honor pioneers pushing the boundaries of science, technology, and advocacy – while fostering industry collaboration, investment, and visibility to accelerate impact and celebrate those rallying around women’s health.
“For far too long, women’s health has been underfunded, undervalued, and underserved. The innovators we’re recognizing are not only advancing groundbreaking science but also reshaping an industry that has historically overlooked half the population. By championing investment and innovation in hormonal health, we can drive lasting change for generations to come,” said Sylvia Kang, CEO and founder of Mira.
Award categories
- Hormonal Health Company of the Year
- Hormonal Health Innovation of the Year
- Hormonal Health Leader of the Year
- Best Use of Data to Close the Hormonal Health Gap
- Hormonal Health Partnership of the Year
How to apply
- Applications open: March 25 – May 25, 2025
- Winners announced: June 20, 2025
- Apply here: https://shop.miracare.com/en-eu/pages/shaw-awards?country=ES
Applications are free, and Mira encourages all brands, businesses, and individuals creating impact in the hormonal health industry to take advantage of this opportunity.
The applications will be reviewed by a distinguished panel of experts – Kathrin Folkendt (Women’s health leader and founder of Femtech Insider), Melissa Barall (Strategic Deal Architect for UHNW & FO) , Ikram Guerd (Women’s health leader at Aspivix) and Sylvia Kang (CEO and founder at Mira).
Winners will receive recognition and new opportunities within the industry. They will gain valuable media exposure, being featured in press releases, industry publications, and showcased on Mira’s platform. Additionally, winners will be invited to speak at Mira-hosted event in San Francisco, giving them the chance to share their expertise with a wider audience. They will also receive exclusive networking access to a community of experts, investors, and leaders in hormonal health, creating opportunities for collaboration and growth. As part of their recognition, winners will be featured in a dedicated episode of Mira’s podcast, allowing them to share their journey and insights.
Applicants are welcome to apply on Mira’s website and learn more about the awards and the application process.
About Mira
Mira is a San Francisco-based hormonal health company providing integrative care and hormonal testing for over 130,000 customers. Mira was founded in late 2015 by a group of scientists, engineers, OBGYN doctors, and business execs to solve the problem of the unavailability of advanced home health testing. The company’s mission is to develop data-driven hormonal health solutions to help women make confident health decisions during every stage of their lives – from the menstrual stage to menopause.
